Adamis Pharmaceuticals Corporation

Company Details:

Company Symbol: ADMP
Sector: Healthcare & Medical Devices
Company Rating:

Related Research

  • 06/05/17 Update Discontinuing Coverage: ADMP
  • 01/19/17 Update ADMP ($3.00, Buy; $5.00 PT): Human Factors Studies (Patient Usability) Could Continue to Delay a Potential FDA Approval of Teva Pharmaceuticals’ Generic EpiPen.
  • 01/19/17 Morning Note B. Riley AM Note: ADMP, ASML, BELFB (initiation), DMRC, EVLV, FNSR, HCHC, OCLR, RUBI; Consumer Products (CL, CLX, KMB, PG)
  • 01/06/17 Update Industry Update - MedTech: What Medical Technology Investors Should Know as the Healthcare Sector Descends on San Francisco on January 9-12, 2017
  • 12/20/16 Initiation of Coverage ADMP ($2.85, Buy; $5.00 PT): Adamis Pharmaceuticals Corporation, Providing High Quality, Low-Cost Solutions for the Healthcare System; Initiating at Buy with a $6.00 PT
  • 12/20/16 Morning Note B. Riley AM Note: ADMP (initiation), NPTN, RDI, SIMO, XOXO